Therapeutic interchange as a cost-containment measure {editorial}.
L E
LE
Achusim
D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics; D003363:Cost Control; D005343:Fibrinolytic Agents / Q000493:pharmacokinetics; D005544:Forecasting; D006635:Histamine H2 Antagonists / Q000493:pharmacokinetics; D006801:Humans; D010952:Plasma Substitutes / Q000493:pharmacokinetics; D013810:Therapeutic Equivalency